Stock Events

Stock Events

Johnson & Johnson 

€22.00
44459
+€0.20+0.92%Friday 07:06

Statistics

Day High
22
Day Low
22
52W High
22
52W Low
15
Volume
0
Avg. Volume
8
Mkt Cap
52.96B
P/E Ratio
-
Dividend Yield
1.97%
Dividend
0.43

Upcoming

Dividends

1.97%Dividend Yield
Sep 2026
€0.11
Jun 2026
€0.11
Mar 2026
€0.10
Dec 2025
€0.10
Sep 2025
€0.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-1.84%

Earnings

Jan 26Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
2.11
2.27
2.43
2.59
Expected EPS
2.5889381240000002
Actual EPS
N/A

Financials

28.88%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
81.83BRevenue
23.63BNet Income

Analyst Ratings

$219.67Average Price Target
The highest estimate is ⁦242.82⁩.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
83%
Hold
17%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ0.MU. It's not an investment recommendation.
Coca-Cola
12835
KO
Realty Income
11619
O
Apple
11406
AAPL
Microsoft
11220
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap368.89B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap251.94B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Show More
CEO
Joaquin Duato
Employees
140800
Country
United States
ISIN
CA47817E1034
WKN
000A3ET7S

Listings

MU
DE
JNJ.MU
F
DE
JNJ0.F
BA
AR
JNJ.BA
BK
TH
JNJ03.BK

0 Comments

Share your thoughts

FAQs

What is Johnson & Johnson stock price today?▼
The current price of JNJ0.MU is €22.00 EUR — it has increased by +0.92% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
What is Johnson & Johnson stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Johnson & Johnson stocks are traded under the ticker JNJ0.MU.
Is Johnson & Johnson stock price growing?▼
JNJ0.MU stock has risen by +2.8% compared to the previous week, the month change is a +3.77% rise, over the last year Johnson & Johnson has showed a +45.7% increase.
What is Johnson & Johnson market cap?▼
Today Johnson & Johnson has the market capitalization of 52.96B
When is the next Johnson & Johnson earnings date?▼
Johnson & Johnson is going to release the next earnings report on January 26, 2027.
What were Johnson & Johnson earnings last quarter?▼
JNJ0.MU earnings for the last quarter are 2.31 EUR per share, whereas the estimation was 2.25 EUR resulting in a +2.68% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Johnson & Johnson revenue for the last year?▼
Johnson & Johnson revenue for the last year amounts to 81.83B EUR.
What is Johnson & Johnson net income for the last year?▼
JNJ0.MU net income for the last year is 23.63B EUR.
Does Johnson & Johnson pay dividends?▼
Yes, JNJ0.MU dividends are paid quarterly. The last dividend per share was 0.11 . As of today, Dividend Yield (FWD)% is 1.97%.
How many employees does Johnson & Johnson have?▼
As of November 4, 2026, the company has 140,800 employees.
In which sector is Johnson & Johnson located?▼
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?▼
Johnson & Johnson has not had any recent stock splits.
Where is Johnson & Johnson headquartered?▼
Johnson & Johnson is headquartered in NEW BRUNSWICK, United States.